5 MAY 2024L AST WORD30Elevating Quality and Collaboration: Advancements in 503B Current Good Manufacturing Practices (cGMP) for Ready-to-Administer Parenteral ProductsDavid Short, Chief Quality Officer, QuVa PharmaCXO INSIGHTSCXO INSIGHTS16Navigating the Horizons: Pharmacy's Dynamic Role in HealthcareNick Capote, Systemwide Director, Oncology, Infusion, and Investigational Drug Pharmacy Services, UCSF Health18Controlling Employer-Sponsored Health Plan Drug CostsRobert Fink, Pharm.D., MBA, FACHE, FASHP, BCPS, System Vice-President, Pharmacy Services, UofL Health20Addressing Social Determinants of Health: A Comprehensive Framework for Pharmacy Practice EnhancementSerena Evans, PharmD, Director, Pharmacy Services- Specialty Pharmacy,Stanford Health Care26Reflections on Oncology Pharmacy Practice in 2023Leslie Young, Pharmacy Manager, Oncology Practice and Sterile Compounding, Kingston Health Sciences Centre22Biosimilar Market Expansion andHealthcare Industry SustainabilitySophia Humphreys,Director, System Pharmacy Formulary Management & Clinical Programs,Sutter Health24Shedding Light on the Challenges in Pharmacy IndustryNeil Creasey, System Director of Pharmacy Operations, Holzer Health System
< Page 4 | Page 6 >